Koller E, McFarland K, Angelle C, Howard J, Ryu D, Dillon K
Acta Neuropathol Commun. 2025; 13(1):51.
PMID: 40055831
PMC: 11887169.
DOI: 10.1186/s40478-025-01968-3.
Wu S, Xie Y, Jiang Y, Zhang X, Zhou Y, Zuo X
Clin Rheumatol. 2025; 44(3):989-998.
PMID: 39812970
DOI: 10.1007/s10067-025-07320-3.
Elango J, Zamora-Ledezma C, Ge B, Hou C, Pan Z, Bao B
Bioengineering (Basel). 2022; 9(7).
PMID: 35877372
PMC: 9311863.
DOI: 10.3390/bioengineering9070321.
Araujo-Pires A, Vieira A, Francisconi C, Biguetti C, Glowacki A, Yoshizawa S
J Bone Miner Res. 2014; 30(3):412-22.
PMID: 25264308
PMC: 4542048.
DOI: 10.1002/jbmr.2376.
Richter J, Capkova K, Hribalova V, Vannucci L, Danyi I, Maly M
Clin Exp Immunol. 2014; 177(1):121-33.
PMID: 24588081
PMC: 4089161.
DOI: 10.1111/cei.12313.
Therapeutic effect of dimethyl dimethoxy biphenyl dicarboxylate on collagen-induced arthritis in rats.
Talaat R, Abo-El-Atta A, Farou S, El-Dosoky K
Chin J Integr Med. 2014; 21(11):846-54.
PMID: 24584757
DOI: 10.1007/s11655-014-1746-1.
IL-4, JAK-STAT signaling, and pain.
Busch-Dienstfertig M, Gonzalez-Rodriguez S
JAKSTAT. 2014; 2(4):e27638.
PMID: 24470980
PMC: 3897502.
DOI: 10.4161/jkst.27638.
Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.
Ling X, Macaubas C, Alexander H, Wen Q, Chen E, Peng S
BMC Med. 2012; 10:125.
PMID: 23092393
PMC: 3523070.
DOI: 10.1186/1741-7015-10-125.
Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Kimata M, Cullins D, Brown M, Brand D, Rosloniec E, Myers L
Arthritis Res Ther. 2012; 14(3):R107.
PMID: 22569209
PMC: 3446484.
DOI: 10.1186/ar3832.
Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.
Kochetkova I, Thornburg T, Callis G, Pascual D
J Immunol. 2011; 187(9):4654-66.
PMID: 21967895
PMC: 3237119.
DOI: 10.4049/jimmunol.1100530.
T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.
Myers L, Cullins D, Brand D, Kleinau S, Stuart J, Kang A
Arthritis Rheum. 2011; 63(9):2661-70.
PMID: 21590683
PMC: 3575180.
DOI: 10.1002/art.30454.
A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis.
Wallis S, Cooney L, Endres J, Lee M, Ryu J, Somers E
Arthritis Res Ther. 2011; 13(1):R15.
PMID: 21294892
PMC: 3241359.
DOI: 10.1186/ar3239.
Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.
Tang B, Cullins D, Zhou J, Zawaski J, Park H, Brand D
Arthritis Res Ther. 2010; 12(4):R136.
PMID: 20615221
PMC: 2945026.
DOI: 10.1186/ar3074.
Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4.
Sarkar S, Cooney L, White P, Dunlop D, Endres J, Jorns J
Arthritis Res Ther. 2009; 11(5):R158.
PMID: 19852819
PMC: 2787258.
DOI: 10.1186/ar2838.
T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.
Tang B, Zhou J, Park J, Cullins D, Yi A, Kang A
Clin Immunol. 2009; 133(1):145-53.
PMID: 19596610
PMC: 2756788.
DOI: 10.1016/j.clim.2009.06.006.
Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells.
Kochetkova I, Trunkle T, Callis G, Pascual D
J Immunol. 2008; 181(4):2741-52.
PMID: 18684965
PMC: 2599931.
DOI: 10.4049/jimmunol.181.4.2741.
Altered endochondral ossification in collagen X mouse models leads to impaired immune responses.
Sweeney E, Campbell M, Watkins K, Hunter C, Jacenko O
Dev Dyn. 2008; 237(10):2693-704.
PMID: 18629872
PMC: 2630710.
DOI: 10.1002/dvdy.21594.
TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y, Saitoh O, McLachlan S, Rapoport B, Kano H, Kumazawa Y
Clin Exp Immunol. 2004; 138(3):417-22.
PMID: 15544617
PMC: 1809247.
DOI: 10.1111/j.1365-2249.2004.02641.x.